@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C02CA04> a ns1:ATCConcept ;
    skos:notation "C02CA04" ;
    skos:prefLabel "Doxazosin"@cs,
        "Doxazosin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026251> a ns1:Ingredient ;
    ns1:contraindicatedWith "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649" ;
    ns1:description "A prazosin-related compound that is a selective alpha-1-adrenergic blocker.     "@en ;
    ns1:hasMechanismOfAction "http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000009919" ;
    ns1:hasMedicinalProduct "http://linked.opendata.cz/resource/sukl/medicinal-product/CARDURA-XL-4-MG",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/DOXAZOSIN-AUROBINDO-4-MG-TABLETY",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/DOXAZOSIN-MYLAN-4-MG",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/DOXAZOSIN-POLPHARMA-4-MG",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/KAMIREN-2",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/KAMIREN-4",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/ZOXON-2",
        "http://linked.opendata.cz/resource/sukl/medicinal-product/ZOXON-4" ;
    ns1:hasPharmacologicalAction "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0543996" ;
    ns1:hasPhysiologicEffect "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008299",
        "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008421",
        "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009911",
        "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000178477" ;
    ns1:mayTreat "http://linked.opendata.cz/resource/ndfrt/disease/N0000001608",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001616",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002499",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003353" ;
    ns1:title "Doxazosin"@cs,
        "Doxazosin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     "@en ;
    ns1:title "Antihypertenzíva"@cs,
        "Antihypertensive agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0543996> a ns1:PharmacologicalAction ;
    ns1:description "Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.     "@en ;
    ns1:title "Alfa-1-adrenergní receptory - antagonisté"@cs,
        "Adrenergic alpha-1 receptor antagonists"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001608> a ns1:DiseaseOrFinding ;
    ns1:description "An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.     "@en ;
    ns1:title "Hyperplazie"@cs,
        "Hyperplasia"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001616> a ns1:DiseaseOrFinding ;
    ns1:description "Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.     "@en ;
    ns1:title "Hypertenze"@cs,
        "Hypertension"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001649> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.     "@en ;
    ns1:title "Hypotenze"@cs,
        "Hypotension"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002499> a ns1:DiseaseOrFinding ;
    ns1:title "Prostatic hyperplasia"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003353> a ns1:DiseaseOrFinding ;
    ns1:description "Inability to empty the URINARY BLADDER with voiding (URINATION).     "@en ;
    ns1:title "Retence moči"@cs,
        "Urinary retention"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000009919> a ns1:MechanismOfAction ;
    ns1:title "Adrenergic alpha1-Antagonists"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008299> a ns1:PhysiologicEffect ;
    ns1:title "Arterial Vasodilation"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008421> a ns1:PhysiologicEffect ;
    ns1:title "Decreased Bladder Sphincter Tone"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009911> a ns1:PhysiologicEffect ;
    ns1:title "Venous Vasodilation"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000178477> a ns1:PhysiologicEffect ;
    ns1:title "Decreased Blood Pressure"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/CARDURA-XL-4-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "CARDURA XL 4 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/DOXAZOSIN-AUROBINDO-4-MG-TABLETY> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "DOXAZOSIN AUROBINDO 4 MG TABLETY"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/DOXAZOSIN-MYLAN-4-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "DOXAZOSIN MYLAN 4 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/DOXAZOSIN-POLPHARMA-4-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "DOXAZOSIN POLPHARMA 4 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/KAMIREN-2> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "KAMIREN 2"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/KAMIREN-4> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "KAMIREN 4"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/ZOXON-2> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "ZOXON 2"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/ZOXON-4> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02CA04" ;
    ns1:title "ZOXON 4"@cs .


